![]() |
ANNUAL MEETING October 3,4,5, 2001 |
![]() |
|
|
|
Name |
status |
Subject |
|
*Michael Blaese |
confirmed |
Therapy by Gene Repair |
|
*Olivier Danos |
confirmed |
Biological and Clinical Features of AAV Vectors |
|
*Leisa Johnson |
confirmed |
Oncolytic Viruses |
|
*Alan Colman |
confirmed |
Potential of Animal Cloning Technologies in Future
Therapies |
|
*Katherine High |
confirmed |
Gene-Assisted Treatment of Hemophilia. Adeno-associated vectors, blood clotting factor, clinical trial |
|
*Holm Schneider |
confirmed |
In Utero Gene Therapy |
|
*Ian Graham (Univ London, Lodon UK) |
confirmed |
Oligonucleotide-based gene correction strategies:
applications to neuromuscular and cardiovascular
diseases |
|
*Roland Mertelsmann (Uni Klinikum, Freiburg i. Br) |
confirmed |
Gene therapy and gene marking concepts in cancer
treatment |
|
*Douglas Losordo (Tufts Univ, Boston, USA) |
confirmed |
Early results from clinical trials of gene therapy for
myocardial angiogenesis. |
|
|
|
|
|
TIME |
EVENT |
Place/Speaker |
|
0830-0900 |
coffee / registration |
Hall Chemistry Building |
|
0900 |
Welcome addresses |
Director / President |
|
0905-0955 |
Leisa Johnson |
Oncolytic Viruses |
|
1000 |
nfp37 poster ads/talks |
|
|
1035 |
coffee break |
|
|
1055 |
nfp 37 poster ads /talks |
|
|
1135 |
Olivier Danos |
Biological and Clinical Features of AAV Vectors |
|
1210-1300 |
Poster session I, drinks, 1300 lunch |
|
|
1400 |
short talks (nfp37 and /or guests) |
|
|
1520 |
Coffee break |
Hall |
|
1600 |
short talks (nfp37 and/or guests) |
|
|
1645 -1730 |
Douglas Losordo |
Early results from clinical trials of gene therapy for
myocardial angiogenesis. |
|
1800 |
Apero |
|
|
|
|
|
|
|
|
|
|
TIME |
EVENT |
Place/Speaker |
|
0830-0900 |
coffee / registration |
Hall Chemistry Building |
|
0900 |
enter |
Lecture Hall |
|
0900-0945 |
Ian Graham |
Oligonucleotide-based gene correction strategies:
applications to neuromuscular and cardiovascular
diseases |
|
0950 |
poster ads /talks |
|
|
1035 |
coffee break |
|
|
1055 |
poster ads/talks |
|
|
1135 |
Michael Blaese |
Therapy by Gene Repair |
|
1210-1300 |
Poster session II, drinks, 1300 lunch |
|
|
1400 |
short talks |
|
|
1520 |
Coffee break |
Hall |
|
1600 |
short talks |
|
|
1700 -1745 |
Katherine High |
Gene-Assisted Treatment of Hemophilia. Adeno-associated vectors, blood clotting factor, clinical trial |
|
1800 |
Apero |
|
|
1900 |
Official dinner |
|
|
|
|
|
|
TIME |
EVENT |
Place/Speaker |
|
0830-0900 |
coffee / registration |
Hall Chemistry Building |
|
0900 |
Welcome |
Director |
|
0910-0955 |
Roland Mertelsmann |
Gene therapy and gene marking concepts in cancer
treatment |
|
1000 |
Scientific presentations |
Main Lecture Hall |
|
1035 |
coffee break |
|
|
1055 |
Symposium 'Gene Therapy research in CH', |
|
|
1135 |
Press / media corner /residual presentations |
Small Lecture Hall /large lecture Hall |
|
1210-1330 |
lunch break / (posters?) |
|
|
1400 |
Presentation of the steering committee for a |
Lecture Hall |
|
1415 |
Holm Schneider |
In Utero Gene Therapy |
|
1500 |
coffee break |
|
|
1520 |
scientific presentations |
main lecture hall |
|
1640 |
Alan Colman |
Potential of Animal Cloning Technologies in Future
Therapies |
|
1730 |
Meeting closure |
|
|
hopefully: |
see you at the next occasion proposed by SGTN |
|
|
|
|
|
|
Time |
Name |
Team |
Abs Nr |
min |
Title |
|
905 |
Johnson, L. |
ONYX pharma., Richmond,USA |
L01 |
45 |
Oncolytic Viruses |
|
950 |
Hellwig, R. |
HOSSLE |
P02 |
5 |
Oligonucleotide-mediated Targeted Gene Repair Of X-linked Chronic Granulomatous ... |
|
955 |
Bernasconi, L. |
FONTANA |
P03 |
5 |
Glioblastoma Multiforme Gene Therapy |
|
1000 |
Dong, Z. |
GUEST |
P51 |
5 |
Overexpression Of Parkinson's Disease-associated Alpha-synuclein(a53t) In The ... |
|
1005 |
Heister, T. |
GUEST |
P52 |
5 |
Hsv/aav Hybrid Vectors Mediate Long-term Gene Expression In Cultured Human Cells |
|
1010 |
Hemmi, S. |
GUEST |
P53 |
5 |
Attenuated Replication-competent Adenoviruses As Tools For Melanoma Therapy |
|
1015 |
Kostic, C. |
GUEST |
P54 |
5 |
Pattern Of Activity Of Viral And Housekeeping Gene Promoters Using Self-inactivating ... |
|
1020 |
BREAK |
COFFEE |
|
|
|
|
1040 |
Pajusola, K. |
GUEST |
P55 |
5 |
Proteasome Activity And A Potentially Different Endosomal Routing Restrict Aav-2 .. |
|
1045 |
Willers, J. |
GUEST |
P56 |
5 |
Interferon Resistance Of Cutaneous T-cell Lymphoma Derived Clonal T-helper 2 Cells .. |
|
1050 |
Foletti, A. |
RUEGG |
M11 |
5 |
Disruption Of Integrin Function By Expressing Partial Regions Of The ... |
|
1055 |
Iggo, R. |
IGGO |
M02 |
20 |
Adenoviruses With Tcf Binding Sites In Multiple Early Promoters Show Enhanced ... |
|
1115 |
Villard, J. |
VILLARD |
M01 |
20 |
Diagnostic Test For Mhc Class Ii Deficiency Patients By Direct Genetic Correction |
|
1135 |
Danos, O. |
Genethon, Paris, France |
L02 |
45 |
Biological And Clinical Features Of Aav Vectors |
|
1220 |
BREAK |
POSTERS & DRINKS |
|
|
|
|
1230 |
Fuhrmann Benzakein, E. |
HERRERA |
P00 |
- |
A Single-gene Approach To Devise Inducible Or Removable Therapeutic Genes: A General ... |
|
1230 |
Genilloud, A. |
RUSCONI |
P01 |
- |
Selection Of Spontaneously Translocating ... |
|
1230 |
Matheux, F. |
VILLARD |
P04 |
- |
Partial And Transient Restoration Of Mhc-ii Molecules In Rfx5-/- Mice By Lentiviral ... |
|
1300 |
BREAK |
POSTERS & LUNCH |
|
|
|
|
1400 |
Aebischer, P. |
AEBISCHER |
M03 |
40 |
Lentiviral Vectors For The Treatment Of Neurodegenerative Disorders |
|
1440 |
Wodnar-Filipowicz, A. |
FILIPOWICZ/ |
M04 |
20 |
Lentivirus-mediated Gene Transfer Into Hematopoietic Precursor Cells From ... |
|
1500 |
Rusconi, S. |
FREY/Rusconi |
M05 |
20 |
Selective Enhancement Of Gene Transfer By Steroid-mediated Gene Delivery (smgd). |
|
1520 |
BREAK |
REFRESHMENTS |
|
|
|
|
1540 |
Greber, U. |
GUEST |
M51 |
20 |
Adenovirus-disassembly Reveals A Function Of Nuclear Histone-h1 In Viral Dna-import .. |
|
1600 |
Hossle, J. |
HOSSLE |
M06 |
20 |
Progress In Somatic Gene Therapy Of X-linked Chronic Granulomatous Disease |
|
1620 |
Baumgartner, I. |
BAUMGARNTER |
M07 |
20 |
Lessons Learned From Vegf Gene Therapy |
|
1640 |
Losordo, D. |
TUFTS, Boston, USA |
L03 |
45 |
Early Results From Clinical Trials Of Gene Therapy For Myocardial Angiogenesis |
|
1730 |
End-day1 |
REFRESHMENTS |
|
|
|
|
Time |
Name |
Team |
Abs Nr |
min |
Title |
|
900 |
Graham, I. |
Univ. London, Egham, UK |
L04 |
45 |
Oligonucleotide-based Gene Correction Strategies: Applications To Neuromuscular And Cardiovascular Diseases |
|
950 |
Arsenijevic, Y. |
GUEST |
P57 |
5 |
Lentiviral-mediated Transfer Of Ciliary ... |
|
955 |
Lobianco, C. |
AEBISCHER |
P09 |
5 |
Dopaminergic Cell Loss Induced By Lentivir... |
|
1000 |
Regulier, E. |
AEBISCHER |
P10 |
5 |
Lentiviral-mediated Delivery Of Mutant ... |
|
1005 |
Odermatt, A. |
FREY/Rusconi |
P13 |
5 |
Selection Of Peptide Ligands Binding To The .. |
|
1010 |
Ashrafuzzaman, M. |
GUEST |
P58 |
5 |
Harmonic Thermodynamical Behavior Of ... |
|
1015 |
Esslinger, C. |
GUEST |
P59 |
5 |
Efficient Transduction Of Dendritic Cells And.. |
|
1020 |
Schafer, B. |
GUEST |
P60 |
5 |
Paired-box Containing Transcription Factor.. |
|
1025 |
Afanasieva, T. |
KLEMENZ |
P22 |
5 |
Single-chain Antibody And Its Derivatives ... |
|
1030 |
BREAK |
COFFEE |
|
|
|
|
1050 |
Schultz, J. |
MOELLING |
P14 |
5 |
Ip-10 Encoding Plasmid Dna Immunization ... |
|
1055 |
Schuemperli, D. |
SCHUEMPERLI |
M16 |
20 |
Stable Transduction And Expression Of ... |
|
1115 |
Brun, C. |
SCHUEMPERLI |
P15 |
5 |
Exon Skipping Of Dystrophin Mrna By ... |
|
1120 |
Jilek, S. |
WALTER |
P16 |
5? |
Monitoring The Maturation Of Dendritic ... |
|
1125 |
Kralisch, S. |
WALTER |
P17 |
5 |
Targeting Of Dendritc Cells By Specific... |
|
1130 |
Li, J. |
VASSALLI |
P18 |
5 |
Adenoviral Gene Transfer Of A Soluble Il-1... |
|
1135 |
Blaese, M. |
VALIGEN Inc, |
L05 |
45 |
Therapy By Gene Repair |
|
1220 |
BREAK |
POSTERS & LUNCH |
|
|
|
|
1230 |
Bensadoun, J. |
AEBISCHER |
P06 |
- |
Neuroprotective Effect Of Interleukin-6 And.. |
|
1230 |
Guillot, S. |
AEBISCHER |
P07 |
- |
Long-term Gene Transfer To The Mouse ... |
|
1230 |
Hussain-khan, H. |
AEBISCHER |
P08 |
- |
Bioartificial Pancreas: Matching Device And .. |
|
1230 |
Ridet, J. |
AEBISCHER |
P11 |
- |
In Vivo Characterization Of A Tetracycline... |
|
1230 |
Schneider, A. |
SCHNEIDER/ Rusconi |
P05 |
- |
Exploring The Limits Of Organellar ... |
|
1230 |
Schwenter, F. |
AEBISCHER |
P12 |
- |
Optimization Of Human Erythropoietin ... |
|
1230 |
Stolarczyk, D. |
GUEST |
P107 |
- |
|
|
1300 |
BREAK |
POSTERS & LUNCH |
|
|
|
|
1400 |
Jones, G. |
MERLO |
M08 |
20 |
The Focal Adhesion Kinase (fak) Is Highly ... |
|
1420 |
Kolakofsky, D. |
KOLAKOFSKY |
M09 |
20 |
Prolonging The Life Span Of Mature Dendritic. |
|
1440 |
Scully, J. |
REHMANN-SUT. |
M10 |
20 |
Perceptions Of Healing Needs: Somatic Gene ... |
|
1500 |
Moelling, K. |
MOELLING |
M12 |
20 |
Cytokine-encoding Dna For Cancer Gene... |
|
1520 |
BREAK |
REFRESHMENTS |
|
|
|
|
1540 |
Walter, E. |
WALTER |
M13 |
20 |
Microparticle-mediated Transfection Of ... |
|
1600 |
Bisoffi, M. |
STADLER/ Cecchini |
M14 |
20 |
Scavenger Receptor Block As Improved ... |
|
1620 |
Mermod, N. |
MERMOD |
M15 |
20 |
A Regulatory Network For The Efficient ... |
|
1640 |
High, K. |
Children's Hosp., Phila. |
L06 |
45 |
Gene-Assisted Treatment of Hemophilia |
|
1730 |
End-day2 |
REFRESHMENTS |
|
|
|
|
1900 |
Dinner |
Invitees |
|
|
|
|
Time |
Name |
Team |
Abs Nr |
min |
Title |
|
900 |
Mertelsmann, R. |
Uni-Klinikum, |
L07 |
45 |
Gene Therapy And Gene Marking Concepts In Cancer Treatment |
|
955 |
Kok, M. |
DREHER |
P20 |
5 |
Live Salmonella Vectors For Antigen Transfer Into Human Dendritic Cells. |
|
1000 |
Obregon, C. |
DREHER |
P21 |
5 |
Salmonella Typhimurium Sipb Protein Modulates Activation And Release Of Il-18 ... |
|
1005 |
Dreher, D. |
DREHER |
M17 |
20 |
From Genomics To Vaccination: Treatment Of Latent Tuberculosis By Recombinant ... |
|
1025 |
BREAK |
COFFEE |
. |
. |
|
|
1045 |
Galeazzi, R. |
INVITED PANELIST symp |
none |
30 |
NF and clinical research, report |
|
1115 |
Diggelmann, H. |
INVITED PANELIST symp |
none |
10 |
NF policy |
|
1125 |
Cavalli, F. |
INVITED PANELIST symp |
none |
10 |
The view of a Dr med/politician |
|
1135 |
Dorsch, K. |
INVITED PANELIST symp |
none |
10 |
Biosafety rules update |
|
1145 |
All |
EVENT/ |
|
|
panel and general discussion |
|
1220 |
BREAK |
POSTERS & LUNCH |
|
|
|
|
1400 |
All |
EVENT/ |
|
|
presentation of steering committee GT |
|
1415 |
Schneider, H. |
Children's Hosp. Erlangen, De |
L08 |
45 |
In Utero Gene Therapy |
|
1500 |
Seemayer, C. |
GAY |
M18 |
20 |
Gene Transfer For Treatment Of Rheumatoid Arthritis |
|
1520 |
BREAK |
REFRESHMENTS |
|
|
|
|
1540 |
Wiznerowicz, M. |
TRONO |
M19 |
20 |
Hematopoietic Stem Cells-directed Gene Therapy: Chronic Granulomatous Disease |
|
1600 |
Colman, A. |
PPL Therapeutics Midlothian, UK |
L09 |
45 |
Potential Of Animal Cloning Technologies In Future Therapies |
|
1700 |
Closure |
Safe return! |
|
|
|
|
BRIEF GEOGRAPHIC DESCRIPTION (see below for maps): |
The annual meeting NFP37 will be hold at the Chemistry
building
(this is number 9 in the
plan
of Perolles site).
We will post some signs: 'NFP37 ANNUAL MEETING'.
BY CAR:
BY TRAIN: at the train station entrance you can take a bus
ticket (1.50 Fr).
Bus Nr 1 will bring you to Perolles (it is the terminal after a five
stops ride, about 5 min).
If you want to walk, you take Blvd. de Perolles until its end (about
15 min).
|
FURTHER INDICATIONS AND MAPS: |
How to reach Fribourg
(German):
(http://www.unifr.ch/wwwunifr/body/planSuisseD.html)
How to reach Fribourg
(French):
(http://www.unifr.ch/wwwunifr/body/planSuisseF.html)
How to move around Fribourg
(French):
(http://www.unifr.ch/wwwunifr/body/planVilleF.html)
How to move around Perolles
(French):
(http://www.unifr.ch/wwwunifr/body/planPerollesF.html)
Railways Time table
(english/french/german/italiano): (http://www.sbb.ch/)
Swissair
Time Table (Zürich and Geneva) :
(http://www.swissair.com/timetable/index.htm)
|
PARKING IN PEROLLES, legend to figure |
|
LODGING DURING THE MEETING |
NFP37 attendees who wish to arrive to Fribourg
the evening before, are recommended to reserve at
one of the following hotels (temporary list).
Please mention the word "Meeting Gene therapy/Gentherapie"
when you reserve a room in one of these hotels,
so you profit by a special price:
Hotels in the region:
(We are currently negotiating special rates for NFP37 attendees
in these
and other hotels,including some bed-and-breakfast, so this list will
become
longer in the next weeks)
|
Color |
Lettering |
Meaning |
|
light purple dots |
1-20 |
UNIFR sites, Perolles (Faculty of sciences) bears Nr 2 |
|
yellow dots |
A-E |
Hotels: A, Golden Tulip // B, Au Parc // C, Alpha // D, de la Rose // E, Sauvage // I, Elite // J, Cité St-Justin // K, Youth Hostel // L, Central |
|
Red dot |
F |
Position of Institutes of Biochemistry and Chemistry |
|
Blue dot |
G |
Position of the Ecole Ingenieurs (EIF) |
|
Green dot |
H |
Train station |
|
Green Dot |
S |
Restaurant San Marco (Dinner 4.10) |

Directions Train-station->Hotel Golden
Tulip
(for invited speakers)
Geneva Airport - Fribourg
Geneva Airport - Lausanne: 45 min
Lausanne-Fribourg: 45 min
-------------------------------------------------------------------------
Fribourg - Geneva Airport
-------------------------------------------------------------------------
Zurich Airport - Fribourg
Zurich Airport - ZH Hauptbahnhof: 10 min.
Zurich Airport - Bern: 90 min.
Zurich Hauptbahnhof - Bern: 70 min.
Bern-Fribourg 25 min
-------------------------------------------------------------------------
Fribourg - Zurich Airport
Fribourg - Bern: 20 min.
Fribourg - Zurich Hauptbahnhof: 95 min.
-------------------------------------------------------------------------
|
|
|
|
|